IOTOD
  • Conference
    • 2023 Conference
      • About
      • AGENDA: IOTOD 2023
      • Faculty
      • Sponsors
    • History
  • Education
    • CME Modules
    • Articles and reports
    • Conference webcasts
    • Further events and educational materials
    • LAB insights report
    • Satellite session: adapting to COVID-19
    • Satellite session: medical cannabis
    • Webinars
  • THN toolkit
    • About
    • Materials
    • Case studies
    • THN network
    • Funding
  • Needs Assessment
  • Newsletter
  • Contact us
  • Register
  • Log In
  • Connect on LinkedIn
  1. IOTOD
  2. IOTOD Conference
  3. History of IOTOD
  4. Dr Marc Bourlière

Dr Marc Bourlière


Head of Hepato-Gastroenterology department, Hôpital Saint Joseph

Marseille, France

Biography

Marc Bourlière received his medical degree in 1987 from Marseilles University in Marseille, France. He completed his fellowship training at Marseilles University hospital and in Beaujon University hospital in Paris. He was an assistant in Hepatology in Conception University hospital in Marseilles prior to taking up his current position as head of the Hepato-Gastroenterology department at Hospital Saint Joseph, also in Marseilles. He has been appointed Associate Professor at the Paris Hospital Medical College.

Dr Bourlière and his group have participated in hepatitis B and C and HCC clinical trials. His research has been within the use and development of non-invasive biomarkers in hepatitis, and currently focuses on the development of new antiviral therapy for hepatitis C and B.

Dr Bourlière has published more than 250 papers or chapters in international journals and books focused on hepatitis B and C. As well as reviewing for many specialist journals, he has served as member of the editorial board of Gastroenterologie, Clinique et Biologique.

Dr Bourlière belongs to the French Agency for AIDS and hepatitis research (ANRS) and he co-chairs the ANRS group that coordinates hepatitis clinical therapeutic trials (CSS13). He belonged to the scientific committee of the HEPATHER cohort. He is also member of several professional societies including the French (AFEF), the American association for study of liver disease (AASLD) and the European associations for the study of the liver (EASL).

Disclosures

  • Receipt of honoraria or consultation fees and participation in a company sponsered speaker’s bureau for AbbVie, Gilead, Janssen, BNS and NSD
  • Home
  • Contact
  • Privacy Policy
  • Connect on LinkedIn
PCM Scientific

© 2025 PCM Scientific


PCM Scientific – 1 Giltspur Street, London, EC1A 9DD, UK

www.pcmscientific.com